ArticleAmerican journal of cancer research2022

Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).

Nicholas R Liguori et al.PubMed ↗Full text ↗

No numbers read from the abstract.